Bookmark and Share

Compound Summary for: CID 179340

asimadoline

Also known as: UNII-D0VK52NV5M; Asimadoline [INN]; EMD 61753; AC1L452B
Molecular Formula: C27H30N2O2   Molecular Weight: 414.5393   InChIKey: JHLHNYVMZCADTC-LOSJGSFVSA-N
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _